Ticker
CRNXCompany Name
CRINETICS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 1.39M | $ 83.59M | 6005.32% |
3/31/2025 | $ 760K | $ 76.41M | 10053.95% |
12/31/2024 | $ 1.04M | $ 69.39M | 6678.15% |
9/30/2024 | $ 1.04M | $ 62.16M | 5982.48% |
6/30/2024 | $ 1.39M | $ 55.06M | 3975.45% |
3/31/2024 | $ 1.97M | $ 46.3M | 2345.24% |
12/31/2023 | $ 4.01M | $ 40.94M | 1020.11% |
9/30/2023 | $ 4.72M | $ 37.27M | 789.24% |
6/30/2023 | $ 4.83M | $ 33.65M | 696.17% |
3/31/2023 | $ 4.29M | $ 30.61M | 714.33% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for CRINETICS PHARMACEUTICALS INC is calculated as follows: SB Comp. [ $ 9.29M ] / Revenues [ $ 392K ]
(=) SB Comp % [ 2369.13% ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.99K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |